» Articles » PMID: 2387295

Susceptibility of Bacteroides Non-fragilis and Fusobacteria to Amoxicillin, Amoxicillin/clavulanate, Ticarcillin, Ticarcillin/clavulanate, Cefoxitin, Imipenem and Metronidazole

Overview
Publisher Springer
Date 1990 Jun 1
PMID 2387295
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The susceptibility of 234 Bacteroides non-fragilis strains and 56 fusobacteria from 12 European centers to amoxicillin, amoxicillin/clavulanate, ticarcillin, ticarcillin/clavulanate, cefoxitin, imipenem and metronidazole was tested and related to beta-lactamase production. Beta-lactamase production was detected in 42.3 % of the Bacteroides strains and 26.8% of the fusobacteria. The MIC90 of amoxicillin for beta-lactamase-negative strains was 0.5 microgram/ml and the MIC90 of ticarcillin 2.0 micrograms/ml. In the case of beta-lactamase-positive strains the MIC90 of amoxicillin (32 micrograms/ml) and ticarcillin (16 micrograms/ml) dropped to less than or equal to 1.0 microgram/ml upon addition of clavulanate; 65.8% of these strains were susceptible to amoxicillin and 98.2% to ticarcillin, but all were susceptible when clavulanate was added. All strains were susceptible to imipenem and metronidazole, and 99.3% to cefoxitin.

Citing Articles

A Review of the Clinical Utilization of Oral Antibacterial Therapy in the Treatment of Bone Infections in Adults.

Haddad N, Ajaz J, Mansour L, Kasemodel R, Jarvis J, Jarad J Antibiotics (Basel). 2024; 13(1).

PMID: 38275315 PMC: 10812599. DOI: 10.3390/antibiotics13010004.


Taxonomy, biology, and periodontal aspects of Fusobacterium nucleatum.

Bolstad A, Jensen H, Bakken V Clin Microbiol Rev. 1996; 9(1):55-71.

PMID: 8665477 PMC: 172882. DOI: 10.1128/CMR.9.1.55.


Susceptibilities of 394 Bacteroides fragilis, non-B. fragilis group Bacteroides species, and Fusobacterium species to newer antimicrobial agents.

Appelbaum P, Spangler S, Jacobs M Antimicrob Agents Chemother. 1991; 35(6):1214-8.

PMID: 1929264 PMC: 284313. DOI: 10.1128/AAC.35.6.1214.


Susceptibilities of 540 anaerobic gram-negative bacilli to amoxicillin, amoxicillin-BRL 42715, amoxicillin-clavulanate, temafloxacin, and clindamycin.

Appelbaum P, Spangler S, Shiman R, Jacobs M Antimicrob Agents Chemother. 1992; 36(5):1140-3.

PMID: 1324639 PMC: 188852. DOI: 10.1128/AAC.36.5.1140.


beta-Lactamase production and susceptibility of US and European anaerobic gram-negative bacilli to beta-lactams and other agents.

Jacobs M, Spangler S, Appelbaum P Eur J Clin Microbiol Infect Dis. 1992; 11(11):1081-93.

PMID: 1295763 DOI: 10.1007/BF01967803.

References
1.
Timewell R, Taylor E, Phillips I . The beta-lactamases of Bacteroides species. J Antimicrob Chemother. 1981; 7(2):137-46. DOI: 10.1093/jac/7.2.137. View

2.
Appelbaum P, Spangler S, Jacobs M . Evaluation of two methods for rapid testing for beta-lactamase production in Bacteroides and Fusobacterium. Eur J Clin Microbiol Infect Dis. 1990; 9(1):47-50. DOI: 10.1007/BF01969535. View

3.
Nord C, Lindmark A, Persson I . Susceptibility of anaerobic bacteria to ALP 201. Antimicrob Agents Chemother. 1989; 33(12):2137-9. PMC: 172835. DOI: 10.1128/AAC.33.12.2137. View

4.
Sweet R . In vitro activity of cefmetazole, cefotetan, amoxicillin-clavulanic acid, and other antimicrobial agents against anaerobic bacteria from endometrial cultures of women with pelvic infections. Antimicrob Agents Chemother. 1987; 31(9):1434-7. PMC: 174958. DOI: 10.1128/AAC.31.9.1434. View

5.
Swenson R . Rationale for identification and susceptibility testing of anaerobic bacteria. Rev Infect Dis. 1986; 8(5):809-13. DOI: 10.1093/clinids/8.5.809. View